Next Generation Protein Sequencing and Characterisation
De novo protein sequencing has become an excellent tool for commercial and non-commercial antibody research and development.
This on-demand webinar, presented by Rapid Novor and hosted by Krishgen, gives exclusive insights into Next Generation Protein Sequencing and Characterisation.
Speaker
Monique Seymour, MSc
Senior Scientific Sales Executive | Rapid Novor
At Rapid Novor, Monique has worked with hundreds of scientists in therapeutic and diagnostic fields globally to understand their goals and apply her proteomics knowledge, together with Rapid Novor’s REmAb® service, to speed up discovery.
Key Learning Objectives
- How Next Generation Protein Sequencing (NGPS) works
- Applications of NGPS to aid engineering and recombinant production of antibodies
- How REmAb® de novo protein sequencing works
Watch Now: Next Generation Protein Sequencing and Characterisation
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- May 15, 2024
- Monique Seymour, MSc, Rapid Novor
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and you'll go straight to the recording — we'll also email you the link.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar